J. S. Biradar
J. S. Biradar publishes mostly in Organic Chemistry, Molecular Biology and Physical and Theoretical Chemistry, on topics such as Synthesis and biological activity, Synthesis and Biological Evaluation and Multicomponent Synthesis of Heterocycles.
- World rank
- #4,828,689 of 7,710,434 ranked researchers
- Rank in India
- #129,382 of 280,097
- Works
- 45
- Citations
- 675
- Citations per work
- 15.0
What does J. S. Biradar research?
J. S. Biradar's work is mostly in Chemistry (80%), Biochemistry, Genetics and Molecular Biology (4%), Pharmacology, Toxicology and Pharmaceutics (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Physical Sciences3679.7%
- Chemistry3679.7%
- Life Sciences49.0%
- Everything else49.0%
- Health Sciences12.3%
- Medicine12.3%
- 1Organic Chemistry77% of their works
- 2Molecular Biology4% of their works
- 3Physical and Theoretical Chemistry3% of their works
- 4Toxicology3% of their works
- 5Pharmacology2% of their works
- 6Pharmacology2% of their works
Research topics
- Synthesis and biological activity
- Synthesis and Biological Evaluation
- Multicomponent Synthesis of Heterocycles
- Synthesis of Indole Derivatives
- Synthesis and Characterization of Heterocyclic Compounds
- Synthesis and Reactions of Organic Compounds
- Bioactive Compounds and Antitumor Agents
- Chemical Synthesis and Reactions
Which keywords describe J. S. Biradar's research?
The keywords of their largest research topics: Anticancer Agents, Heterocyclic Compounds, Medicinal Chemistry, Synthesis, Tubulin Inhibitors, Vascular Targeting Agents, Organic Synthesis and Biological Evaluation.
- Toxicology
- Esterification
- Oxazolones
- Triazines
- Quinone Methides
- Asymmetric Catalysis
- Multicomponent Reactions
- Derivatives
- Oxidation
- Catalysis
- Catalyst
- Biological Evaluation
- Vascular Targeting Agents
- Synthesis
- Heterocyclic Compounds
- Anticancer Agents
- Medicinal Chemistry
- Tubulin Inhibitors
- Organic Synthesis
- Drug Discovery
- Antimicrobial Activity
- Green Chemistry
- Heterocycles
- Heterocyclic Synthesis
- Quinoxaline
- Chemoselective
- Antimicrobial
- Imidazoles
- Acylation
- Quinones
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 30 words, with their numbers
- Anticancer Agents463 topics
- Heterocyclic Compounds422 topics
- Medicinal Chemistry422 topics
- Synthesis313 topics
- Tubulin Inhibitors281 topic
- Vascular Targeting Agents281 topic
- Organic Synthesis252 topics
- Biological Evaluation242 topics
- Drug Discovery242 topics
- Catalyst212 topics
- Antimicrobial Activity182 topics
- Catalysis182 topics
- Green Chemistry182 topics
- Oxidation182 topics
- Heterocycles172 topics
- Derivatives141 topic
- Heterocyclic Synthesis141 topic
- Multicomponent Reactions141 topic
- Quinoxaline141 topic
- Asymmetric Catalysis111 topic
- Chemoselective112 topics
- Quinone Methides111 topic
- Antimicrobial101 topic
- Triazines101 topic
- Imidazoles71 topic
- Oxazolones71 topic
- Acylation41 topic
- Esterification41 topic
- Quinones41 topic
- Toxicology41 topic
Where does J. S. Biradar work?
J. S. Biradar's main affiliation in the publication record is Gulbarga University, India.
How many publications and citations does J. S. Biradar have?
OpenAlex counts 45 works and 675 citations for J. S. Biradar, an h-index of 11, ranking #4,828,689 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about J. S. Biradar. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.